Document Detail


Metabolic Profiling in Multiple Sclerosis and other Disorders by Quantitative Analysis of Cerebrospinal Fluid Using Nuclear Magnetic Resonance Spectroscopy.
MedLine Citation:
PMID:  21466459     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Cerebrospinal fluid (CSF) is being analyzed for the diagnosis of a variety of neurological diseases. Among the methods employed, metabolomics and proteomics are increasingly gaining popularity. At present, sensitivity and, in particular, specificity are limited in CSF metabolomics by nuclear magnetic resonance (NMR) spectroscopy. Nonetheless, progress is being made by studying more and more well-defined and homogeneous patient cohorts. This review starts off with a brief overview of classical CSF analysis in multiple sclerosis (MS), followed by a description of NMR spectroscopy in general metabolic CSF analysis. The subsequent sections focus on metabolomic profiling of CSF by NMR spectroscopy in MS and other neurological disorders. Currently existing results are reviewed and compared, and the potential and limits of this approach are discussed. In addition, several methodological questions are addressed, and the prospects for future developments are briefly outlined.
Authors:
N W Lutz; P J Cozzone
Related Documents :
12112509 - Magnetic resonance safety testing of a newly-developed fiber-optic cardiac pacing lead.
19411189 - Intraprocedural reconstruction of the left atrium and pulmonary veins as a single navig...
15788579 - Evaluation of liver metastases after radiofrequency ablation: utility of 18f-fdg pet an...
21479849 - In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series wi...
20142349 - Irreversible electroporation: a new challenge in "out of operating theater" anesthesia.
11687689 - Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation...
838559 - Focal spots: iii. field characteristics.
1950869 - Cancer of the endometrium: value of mr imaging in determining depth of invasion into th...
11461849 - Uterine artery embolization for the treatment of adenomyosis: clinical response and eva...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-5
Journal Detail:
Title:  Current pharmaceutical biotechnology     Volume:  -     ISSN:  1873-4316     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960530     Medline TA:  Curr Pharm Biotechnol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Centre de Résonance Magnétique Biologique et Médicale, UMR CNRS 6612, Faculté de Médecine de la Timone, Université Aix-Marseille, 27 bd. Jean Moulin, F-13005 Marseille, France. Norbert.Lutz@univmed.fr.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lipid Mediator Profiling in Pulmonary Disease.
Next Document:  Harnessing Metabolomics for Nutrition Research.